Skip to main content

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Tariff threats are fueling a new wave of U.S. manufacturing investments from the pharmaceutical industry.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.